All Rankings

Recently Funded Biotech Companies in the US 2026 (Last 180 Days)

Private biotechnology and genomics companies headquartered in the United States whose latest recorded funding round was announced in the last 180 days, newest first.

Known total funding for 99 of 100 ranked companies: $18.7B.

Showing top 100 matching companies · Ranked by most recent funding

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&countries=United+States&fundedAfter=2026-05-23&operatingStatus=active&sort=last_funding_date&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by most recent announced round. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

26
EIT Pharma

EIT Pharma develops treatments for chronic hepatitis D and acute respiratory infection, with cand...

Kirkland, United States1–10Biotech, Healthcare
Series ATotal funding$35.0MAug 2026
27
AusperBio

AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV tr...

San Francisco, United StatesBiotech, Healthcare
Series CTotal funding$183.0MAug 2026
28
Airway Therapeutics

Airway Therapeutics develops zelpultide alfa, a recombinant protein for acute and chronic inflamm...

Marietta, United States1–10Biotech, Drug Discovery
Series ETotal funding$50.0MAug 2026
29
KaliVir Immunotherapeutics

KaliVir Immunotherapeutics develops next-generation oncolytic viral immunotherapy programs for ca...

Pittsburgh, United States11–50Biotech, Healthcare
Extension RoundTotal funding$14.0MAug 2026
30
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series DTotal funding$473.3MAug 2026
31
Gamgee

Gamgee builds personalized mRNA cancer vaccines from each dog's tumor to help its immune system f...

San Francisco, United States1–10Artificial Intelligence, Biotech
SeedTotal funding$4.0MAug 2026
32
Leal Therapeutics

Leal Therapeutics develops first-in-class neuro-metabolic therapeutics for high-need CNS disorder...

WORCESTER, United States11–50Biotech, Healthcare
Extension RoundTotal funding$163.5MAug 2026
33
Remepy

Remepy pioneers Hybrid Drugs that combine pharmaceutical treatments with targeted digital interve...

New York, United States11–50Artificial Intelligence, SaaS
Series ATotal funding$51.0MAug 2026
34
Infinimmune

Infinimmune discovers and engineers antibodies already proven in people, then advances these huma...

South San Francisco, United States1–10Biotech, Healthcare
Series ATotal funding$87.0MAug 2026
35
Aureka Biotechnologies, Inc.

Aureka Biotechnologies is a biotech startup democratizing pharmaceutical discovery through AI-dri...

Laguna Hills, United States51–200Artificial Intelligence, Biotech
Series BTotal funding$100.0MAug 2026
36
Remedium

Boston-based gene therapy biotech developing innovative treatments for people with a broad range ...

Boston, United States11–50Biotech
Series ATotal funding$12.6MAug 2026
37
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
38
DashBio

AI and robotics enabled drug development, starting with clinical bioanalysis.

Boston, United States11–50Biotech, Life Sciences
Series ATotal funding$47.5MAug 2026
39
Plantible Foods

Biology company producing Rubi Protein from lemna plants for sustainable food ingredients.

San Marcos, United States11–50Food Tech, Sustainability
Extension RoundTotal funding$61.5MAug 2026
40
Expedition Therapeutics

Clinical-stage biotech advancing a Phase 2 COPD therapy.

San Francisco, United States1–10Biotech, Healthcare
Series BTotal funding$280.0MAug 2026
41
Claris Bio

Claris Bio is a privately-held company developing a topical formulation of innovative therapies f...

Jersey City, United States1–10Biotech, Healthcare
Series BTotal funding$175.0MAug 2026
42
Inocras

Bioinformatics-led company using whole-genome data and proprietary analytics to deliver curated, ...

San Diego, United States51–200Biotech, Healthcare
Series BTotal funding$60.0MAug 2026
43
InduPro

Discovering and redefining cell-surface interactions to modulate biological disease pathways

Seattle, United States11–50Biotech
Series BTotal funding$162.0MAug 2026
44
Crystalys Therapeutics

Clinical-stage biopharmaceutical company focused on advancing innovative therapies to address the...

San Diego, United States11–50Biotech, Healthcare
Series BTotal funding$335.0MJul 2026
45
Core Biomedicine

UTokyo IPC life science portfolio company

Boston, United States1–10Biotech, Healthcare
Series ATotal funding$30.9MJul 2026
46
N-Zyme Biomedical

Reflux disease therapeutics platform

Wauwatosa, United States1–10Biotech
Series ATotal funding$4.6MJul 2026
47
Transcripta Bio

AI-powered drug discovery for neurological diseases

Palo Alto, United States11–50Artificial Intelligence, Biotech
Series ATotal funding$34.0MJul 2026
48
TRELLIS BIOSCIENCE, INC.

R&D company with 12 SBIR/STTR awards from Department of Health and Human Services.

Redwood City, United States1–10Biotech, Healthcare
Series CTotal funding$19.0MJul 2026
49
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
50
ChronicleBio

ChronicleBio builds an AI-ready, multi-omic data ecosystem to advance biomarker discovery, patien...

Menlo Park, United States11–50Artificial Intelligence, Biotech
Venture RoundTotal funding$5.4MJul 2026